Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Phase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes Clinical Trials Resources presented on Clinical Trials Search is not meant to be a substitute for proven health advice, calls or treatment with a real medical. We aren't mDs. Always consult your doctor on Phase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Phase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes Clinical research trials and Phase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes healthcare trials take place in a lot of of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectiveness of new does drugs. The function of the studies / projects is to figure out specific human medical questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to find cures for all varieties of conditions, like Phase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes. Phase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes Clinical Trials and other clinical trials allow volunteers to access health treatment options before they are available to the masses. Many times the subjects receive professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Phase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes clinical trial. Human subjects often obtain the finest healthcare possible for their Phase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes condition. Hazards are a reality, nevertheless, and might include additional or frequent dr. calls, health hazards (potentially life-jeopardizing), and/or the treatment being uneffective. Trials are federally regulated with stern guidelines to protect clinical trials patients.

Home > "P" Clinical Trials Conditions > Phase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes

Phase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes



Phase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes

For Condition: Open-Angle Glaucoma,Ocular Hypertension
Status: Recruiting
Sponsor(s): Alcon Research ,
Synopsis: To monitor iris pigmentation changes over a five year period in subjects with open-angle glaucoma or ocular hypertension who have experienced an iris pigmentation change while dosing with TRAVATAN.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Subjects of any race and of either sex diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component) or ocular hypertension who have experienced an iris pigmentation change while dosing with TRAVATAN and who are currently using TRAVATAN
Total Enrollment: 

Location and Contact Information:

Alcon Call Center For Locations *Recruiting*
Multiple Cities & Multiple States,  Texas, 
United States
Recruiting  


Additional Information:
Study ID Numbers:
  C-01-79;  C-01-79
Study Start Date: 
Record last reviewed: June 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00047554

Other Ocular Hypertension Studies:
1. Phase II safety and efficacy study to evaluate a glaucoma therapy in open-angle glaucoma or ocular hypertension patients

2. Phase 3 study to evaluate IOP lowering therapy in open angle glaucoma and ocular hypertension C-01-69

3. Phase 3 study to evaluate IOP lowering therapy in open angle glaucoma and ocular hypertension C-01-70

4. Phase II safety and efficacy study to evaluate a glaucoma therapy in open-angle glaucoma or ocular hypertension patients

5. Phase 4 study comparing IOP lowering in OAG or OH in Caucasian or Japanese subjects C-02-32

Related Studies:

Other Ocular Hypertension Clinical Trials
Other Texas Clinical Trials
Other Multiple Cities & Multiple States Clinical Trials

Phase IV study of TRAVATAN 0.004% in subjects with iris pigmentation changes

Modify your Search

  Other Ocular Hypertension Clinical Trials
  Other Texas Clinical Trials
  Other Multiple Cities & Multiple States Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103